Evidence map›Paper›PMID 27808163›Full record

ReviewNPJ primary care respiratory medicine2016

Recent developments in the diagnosis and management of tuberculosis.

Giorgia Sulis, Rosella Centis, Giovanni Sotgiu, Lia D'Ambrosio, Emanuele Pontali, Antonio Spanevello, Alberto Matteelli, Alimuddin Zumla, Giovanni Battista Migliori

Abstract readReview
In one paragraph

Review in NPJ primary care respiratory medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Potential Diagnostic Properties of Chest Ultrasound in Thoracic Tuberculosis-A Systematic Review.International journal of environmental research and public health · 2018
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Structure, mechanism and inhibition of anthranilate phosphoribosyltransferase.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  10. Detecting rifampin and isoniazid resistance inJournal of clinical tuberculosis and other mycobacterial diseases · 2022
    Article
  11. The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group.European respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Giorgia SulisDepartment of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV and TB elimination, University of Brescia, Brescia, Italy.ORCID 0000-0001-6641-0094
Rosella CentisWHO Collaborating Centre for TB and Lung Diseases, Maugeri Institute, IRCCS, Italy.
Giovanni SotgiuClinical Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari-Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy.
Lia D'AmbrosioWHO Collaborating Centre for TB and Lung Diseases, Maugeri Institute, IRCCS, Italy.
Emanuele PontaliDepartment of Infectious Diseases, Galliera Hospital, Genova, Italy.
Antonio SpanevelloPneumology Unit, Maugeri Institute, IRCCS, Tradate, Italy.
Alberto MatteelliDepartment of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV and TB elimination, University of Brescia, Brescia, Italy.
Alimuddin ZumlaDivision of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK.
Giovanni Battista MiglioriWHO Collaborating Centre for TB and Lung Diseases, Maugeri Institute, IRCCS, Italy.ORCID 0000-0002-2597-574X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) is a major public health issue worldwide, with ~9.6 million new incident cases and 1.5 million deaths in 2014. The End-TB Strategy launched by the World Health Organization in the context of the post-2015 agenda aims to markedly abate the scourge of TB towards global elimination, by improving current diagnostic and therapeutic practices, promoting preventative interventions, stimulating government commitment and increased financing, and intensifying research and innovation. The emergence and spread of multidrug-resistant strains is currently among the greatest concerns, which may hinder the achievement of future goals. It is crucial that primary healthcare providers are sufficiently familiar with the basic principles of TB diagnosis and care, to ensure early case detection and prompt referral to specialised centres for treatment initiation and follow-up. Given their special relationship with patients, they are in the best position to promote educational interventions and identify at-risk individuals as well as to improve adherence to treatment.

Indexed as

Antitubercular AgentsDrug Therapy, CombinationHumansInterferon-gamma Release TestsTuberculin TestTuberculosis, Multidrug-ResistantTuberculosis, PulmonaryAntitubercular Agents

Identifiers

PMID27808163
PMCPMC5093435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.